New Delhi, Jan 3: The Serum Institute of India, the world’s biggest manufacturer of vaccines, has said it is making between 50 and 60 million doses a month of the AstraZeneca/Oxford vaccine, which is cheaper than the Pfizer-BioNTech jab and easier to store and transport. India has set an ambitious target of inoculating 300 million of its 1.3 billion people by mid-2021.
The institute said that it will sell Oxford vaccine to government at Rs 200/ and to public at Rs 1000.
Countries around the globe are hoping that the roll-out of vaccines will bring under control a pandemic which has infected 84.6 million people and killed more than 1.8 million since it first emerged in China just over a year ago. (Agencies)